Computational Chemistry/Drug Design
Previous chapter - Macromolecular chemistry
Computer Aided Drug design
This area covers the use of electronic structure theories to de novo design of drugs, extraction of structure activity relationships and development of pharmacophores to rationalise the drug's mechanism. Computations, proteomics and genomics have advanced considerably since Richard's book and maybe new definitions are needed.
W. G. Richards, Quantum Pharmacology, (Butterworths,London,1977).
A lot of work goes into developing Quantitative Structure Activity Relationships. This can be done by regression analysis even where there is no adequate model of the active site of the process. Some examples are being extracted from literature which we have in the Chemistry Library, (much literatuire of relevance is in biological and pharmacological journals. Some QSAR work uses classic physical organic chemistry such as the Taft and Hammett equations, whereas in recent work all manner of unusual properties may be incorporated into a QSAR.
There is even interest in exotic artificial intelligence technologies such as neural nets. A new technique in this area is known as Support vector machines.
Hansch, C. and Leo, A. Exploring QSAR: ACS Professional Reference Book, (American Chemical Society, Washington, DC,1995).
Neural Nets to Design Drugs
This is a comparatively new area of chemistry / chemo-informatics but it already has a classic textbook:
J. Zupan and J. Gasteiger, Neural Networks in Chemistry and Drug Design: An Introduction, 2nd Edition, Wiley, 1999, ISBN: 3-527-29779-0.
- edited Andrew Vinter and Mark Gardner Molecular modelling and drug design, (Boca Raton:CRC Press,1994), ISBN 0849377722.
Next Chapter - Continuum solvation models